 

PARP Inhibitors Veliparib Treat For Breast Cancer CAS 912444-00-9

$1

≥1
Gram

Payment Type:

T/T

Incoterm:

CIF

Min. Order:

1 Gram

Transportation:

Air

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: 912444-00-9

Brand: VOLSENCHEM

Supply Ability & Additional Information

Packaging: As Quantity

Productivity: As Order

Transportation: Air

Place of Origin: CHINA

Supply Ability: IN STOCK

Payment Type: T/T

Incoterm: CIF

Packaging & Delivery

Selling Units:: Gram

Package Type:: As Quantity

Veliparib CAS number is 912444-00-9, research and development code is ABT-888, he developed the third generation of active and selective PARP inhibitors of benzimidazole structure developed by AbbVie in 2006. Mainly acts on PARP-1 and PARP-2. At present, veliparib combined with whole brain radiotherapy for metastatic brain tumors has entered the stage II clinical stage, and it is also used in the stage III clinical stage for the treatment of metastatic breast cancer, colon cancer...

Product Categories : Active Pharmaceutical Ingredients

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Amy Cheng
*Email:
*Message:

Your message must be between 20-8000 characters